Terms: = Kidney tumors AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
91 results:
1. Pharmacokinetics of the KRAS
Loos NHC; Retmana IA; Rijmers J; Wang Y; Gan C; Lebre MC; Sparidans RW; Beijnen JH; Schinkel AH
Biomed Pharmacother; 2023 Oct; 166():115304. PubMed ID: 37586117
[TBL] [Abstract] [Full Text] [Related]
2. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
[TBL] [Abstract] [Full Text] [Related]
3. [Quantitative assessment of breast cancer resistance protein during pregnancy in rabbits].
Popova NM; Slepnev AA; Abalenikhina YV; Shchulkin AV; Rokunov ED; Yakusheva EN
Biomed Khim; 2023 Feb; 69(1):72-77. PubMed ID: 36857429
[TBL] [Abstract] [Full Text] [Related]
4. A Pan-Cancer Landscape of abcg2 across Human Cancers: Friend or Foe?
Lyu C; Wang L; Stadlbauer B; Buchner A; Pohla H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555598
[TBL] [Abstract] [Full Text] [Related]
5. Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
Sharma P; Singh N; Sharma S
J Biochem Mol Toxicol; 2023 Mar; 37(3):e23269. PubMed ID: 36507589
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study.
Nio Y; Ishida H; Matsumoto N; Kusumoto S; Kubota Y; Tsunoda T; Sasaki Y; Fujita KI
BMC Pulm Med; 2022 Nov; 22(1):454. PubMed ID: 36451169
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract] [Full Text] [Related]
8. ABCB1 restricts brain accumulation of the novel RORγ agonist cintirorgon, while OATP1A/1B and CYP3A limit its oral availability.
Li W; Lehutová D; Sparidans RW; Heydari P; Wang J; Lebre MC; Beijnen JH; Schinkel AH
Eur J Pharm Biopharm; 2022 Aug; 177():135-146. PubMed ID: 35772614
[TBL] [Abstract] [Full Text] [Related]
9. Noninvasive Evaluation of Multidrug Resistance via Imaging of abcg2/bcrp Multidrug Transporter in Lung Cancer Xenograft Models.
Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L
Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142
[TBL] [Abstract] [Full Text] [Related]
10. ABCB1 limits brain exposure of the KRAS
Loos NHC; Retmana IA; Li W; Martins MLF; Lebre MC; Sparidans RW; Beijnen JH; Schinkel AH
Pharmacol Res; 2022 Apr; 178():106137. PubMed ID: 35192958
[TBL] [Abstract] [Full Text] [Related]
11. Expression and Functional Contribution of Different Organic Cation Transporters to the Cellular Uptake of Doxorubicin into Human Breast Cancer and Cardiac Tissue.
Otter M; Csader S; Keiser M; Oswald S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008681
[TBL] [Abstract] [Full Text] [Related]
12. Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat.
Mitsuboshi S; Niimura T; Kanda M; Ishida S; Zamami Y; Ishizawa K
Ann Pharmacother; 2022 Aug; 56(8):910-915. PubMed ID: 34726078
[TBL] [Abstract] [Full Text] [Related]
13. kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.
Li F; Aljahdali IAM; Zhang R; Nastiuk KL; Krolewski JJ; Ling X
J Exp Clin Cancer Res; 2021 Aug; 40(1):254. PubMed ID: 34384473
[TBL] [Abstract] [Full Text] [Related]
14. Steroid receptor RNA activator inhibits the migration, invasion and stemness characteristics of renal cell carcinoma cells.
Zhang C; Zhu N; Liu C; Wu H; Yin Y; Shi Y; Liao D; Qin L
Int J Mol Med; 2020 Nov; 46(5):1765-1776. PubMed ID: 33000206
[TBL] [Abstract] [Full Text] [Related]
15. Effect of ABC transporter expression and mutational status on survival rates of cancer patients.
Kadioglu O; Saeed MEM; Munder M; Spuller A; Greten HJ; Efferth T
Biomed Pharmacother; 2020 Nov; 131():110718. PubMed ID: 32932043
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by abcg2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract] [Full Text] [Related]
17. β-Sitosterol Reverses Multidrug Resistance via bcrp Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract] [Full Text] [Related]
18. Transcription factor-mediated regulation of the bcrp/
Gorczyca L; Aleksunes LM
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):239-253. PubMed ID: 32077332
[No Abstract] [Full Text] [Related]
19. Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance.
Tóth S; Szepesi Á; Tran-Nguyen VK; Sarkadi B; Német K; Falson P; Di Pietro A; Szakács G; Boumendjel A
Molecules; 2020 Feb; 25(3):. PubMed ID: 32050702
[TBL] [Abstract] [Full Text] [Related]
20. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
[TBL] [Abstract] [Full Text] [Related]
[Next]
